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Introduction {#sec1}
============

Since the first derivation of mouse embryonic stem cells (mESCs) ([@bib1; @bib8]), several culture conditions have been developed for the maintenance of undifferentiated mESCs in vitro, including the use of serum-containing medium supplemented with leukemia inhibitory factor (LIF) ([@bib11; @bib13]) as well as serum-free N2B27 medium supplemented with LIF and bone morphogenetic protein 4 (BMP4) ([@bib17]). LIF promotes mESC self-renewal by activating signal transducer and activator of transcription 3 (STAT3) ([@bib9]), while BMP4 can replace serum in supporting mESC self-renewal mediated by LIF/STAT3 ([@bib17]). In 2008, we found that mESC self-renewal can be efficiently maintained by two small molecule inhibitors (2i), CHIR99021 and PD0325901 (CHIR and PD hereinafter) ([@bib18]). CHIR and PD maintain self-renewal through inhibition of glycogen synthase kinase 3 (GSK3) and mitogen-activated protein kinase kinase (MEK), respectively.

Previous reports have shown that inhibition of GSK3 by CHIR promotes mESC self-renewal through activation of Wnt/β-catenin signaling pathway ([@bib6]). In the absence of Wnt ligand or CHIR, T cell factor 3 (TCF3) occupies the promoter regions of many pluripotency genes (e.g., *Nanog*, *Esrrb*, etc.) and functions as a transcriptional repressor ([@bib6]). Upon CHIR treatment, cytosolic β-catenin is stabilized and then translocates into the nucleus, where it binds to TCF3 and relieves its transcriptional repressing effect, leading to the upregulation of Wnt/β-catenin downstream target genes *Nanog* and *Esrrb* as well as other pluripotency genes suppressed by TCF3 such as *Oct4* and *Sox2* ([@bib6]).

In mESCs, CHIR alone can only maintain short term (\<1 week) self-renewal, after which mESCs will gradually undergo non-neural differentiation. LIF or PD, when supplemented with CHIR, is able to block such differentiation induced by CHIR and therefore maintains long-term self-renewal of mESCs ([@bib18]). How CHIR collaborates with LIF or PD to maintain ESC self-renewal, however, remains poorly understood. We speculated that activation of Wnt/β-catenin signaling by CHIR can upregulate the expression of both self-renewal-promoting genes and genes that induce differentiation, and addition of LIF or PD can repress the expression of differentiation genes induced by CHIR. In this study, we sought to dissect the effect of CHIR on promoting self-renewal from its effect on inducing differentiation. We identified *Klf2* and *Tfcp2l1* as the two key self-renewal-promoting targets of CHIR. When simultaneously overexpressed, these two genes can recapitulate the effect of 2i or LIF/CHIR on promoting mESC self-renewal.

Results {#sec2}
=======

Genome-Scale Identification of Transcription Factors Differentially Regulated in mESCs by LIF and LIF/CHIR {#sec2.1}
----------------------------------------------------------------------------------------------------------

Inhibition of GSK3 by CHIR is likely to have pleiotropic transcriptional effects. To facilitate the identification of the self-renewal-promoting gene sets upregulated by CHIR in undifferentiated mESCs, we performed a gene expression microarray analysis in C57BL/6 mESCs treated with LIF or LIF/CHIR. LIF alone is not sufficient to maintain C57BL/6 mESC self-renewal under feeder-free condition and addition of CHIR is required ([@bib14]). Because the major effect of CHIR is to promote C57BL/6 mESC self-renewal when LIF is present, we reasoned that by comparing gene expression profiles of C57BL/6 mESCs treated with LIF or LIF/CHIR, we should be able to narrow down CHIR targets that are associated with pluripotency maintenance. Candidate genes were first screened for changes of 1.5-fold or greater on expression level between LIF/CHIR and LIF conditions (GEO: [GSE50393](ncbi-geo:GSE50393){#intref0010}, p value \< 0.01). Gene sets up- or downregulated by CHIR were then filtered according to published genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) data of OCT4, NANOG, and TCF3 ([@bib6]). From such comparison, we singled out 25 candidates whose promoter regions are occupied by canonical Wnt transcription factor TCF3 as well as core pluripotency factors OCT4 and NANOG ([Table S1](#mmc1){ref-type="supplementary-material"}). Among these 25 candidates, 16 are upregulated and 9 are downregulated ([Figures 1](#fig1){ref-type="fig"}A and 1B) after CHIR treatment.

To further narrow down these candidates, we included microarray data from XAV939-treated cells (GEO: [GSE31461](ncbi-geo:GSE31461){#intref0015}) ([@bib5]) as a filter. Authentic CHIR target genes should have an opposite expression pattern between CHIR and XAV939 treatments, as XAV939 is a potent inhibitor of Wnt/β-catenin signaling pathway. At this point, 18 of the 25 candidate genes showed the expected expression pattern. To further validate this result, we checked the expression pattern of the 18 genes in the microarray data collected from 2i-treated cells (GEO: [GSE46369](ncbi-geo:GSE46369){#intref0020}) ([@bib15]). In 2i condition, authentic CHIR candidate targets should have a similar expression profile as CHIR alone condition. Finally, ten genes were left for our further investigation, among which nine are transcription factors ([Figure 1](#fig1){ref-type="fig"}A). Transcription factors upregulated after CHIR treatment include *Axns*, *Afhx2*, *Klf2*, *Tfcp2l1*, and *Lefty2*. Transcription factors downregulated after CHIR treatment include *Foxp1*, *Gadd45 g*, *Insm1*, and *Otx2* ([Figures 1](#fig1){ref-type="fig"}A and 1B). We focused on genes that are upregulated in LIF/CHIR condition compared with LIF alone and that are specifically expressed in pluripotent stem cells. Three genes, *Klf2*, *Tfcp2l1*, and *Lefty2*, comply with all these rules. Their expression levels in LIF/CHIR and LIF alone conditions were further validated by qRT-PCR analysis. Upon CHIR treatment, *Klf2*, *Tfcp2l1*, and *Lefty2*, as well as *Axin2*, a well-known target of the canonical Wnt/β-catenin signaling, were significantly upregulated while the expression of *Oct4*, a negative control for CHIR treatment, remained unchanged ([Figure 1](#fig1){ref-type="fig"}C). Western blot analysis also confirmed the upregulation of KLF2 and TFCP2L1 by CHIR at the protein level ([Figure 1](#fig1){ref-type="fig"}D). When overexpressed, *Klf2* or *Tfcp2l1*, but not *Lefty2*, was able to maintain C57BL/6 mESC self-renewal under feeder-free condition in the presence of LIF and serum ([Figure 1](#fig1){ref-type="fig"}E), which is consistent with our previous findings ([@bib15]). These results suggest that *Klf2* and *Tfcp2l1* are potentially the critical CHIR downstream targets responsible for mediating mESC self-renewal.

Forced Expression of *Klf2* and *Tfcp2l1* Recapitulates the Effect of 2i on Promoting mESC Self-Renewal {#sec2.2}
-------------------------------------------------------------------------------------------------------

To further examine whether *Klf2* and *Tfcp2l1* can substitute the effect of 2i on promoting mESC self-renewal, we generated 46C mESCs expressing *Klf2* (PB-*Klf2* mESCs), *Tfcp2l1* (PB-*Tfcp2l1* mESCs), or both (PB-*Tfcp-Klf* mESCs) using the PiggyBac (PB) transposon-based vector. 46C mESCs were derived from 129 mouse strain and can be maintained under feeder-free condition in the presence of LIF and serum. The expression of KLF2 and TFCP2L1 proteins in the established cell lines was confirmed by western blot ([Figure 2](#fig2){ref-type="fig"}A). As expected, 46C mESCs transfected with PB empty vector differentiated or died within two passages in N2B27/PD condition. PB-*Klf2*, PB-*Tfcp2l1*, and PB-*Tfcp-Klf* mESCs, however, could be continuously propagated in N2B27/PD condition without overt differentiation ([Figures 2](#fig2){ref-type="fig"}B and 2C). Previous studies have shown that either *Klf2* or *Tfcp2l1* can partially recapitulate the effect of PD in promoting ESC self-renewal ([@bib15; @bib16]). Indeed, PB-*Tfcp-Klf* mESCs could be continuously propagated in N2B27 only while PB-*Klf2* and PB-*Tfcp2l1* mESCs could not survive beyond five passages under this condition ([Figures 2](#fig2){ref-type="fig"}D--2F), suggesting that *Klf2* and *Tfcp2l1* acts synergistically to recapitulate the effect of 2i on promoting ESC self-renewal. The results were validated in another ESC line, the C57BL/6 ESCs ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B).

Next, we tested whether the effect of *Klf2* and *Tfcp2l1* on ESC self-renewal is reversible. Based on the Cre/loxP recombination system, we constructed a double overexpression vector ([Figure 2](#fig2){ref-type="fig"}G) in which the coding sequences of *Klf2* and *Tfcp2l1*, linked by *2A* sequence, were flanked with loxP sites. The coding sequence of GFP was introduced in-frame following the loxP cassette to serve as a recombination reporter. In consistence with previous results, mESCs stably transfected with loxP-*Tfcp2l1-2A-Klf2-STOP-loxP* transgene (loxP-*Tfcp*-*Klf* mESCs hereinafter) could self-renew in N2B27 only condition ([Figure 2](#fig2){ref-type="fig"}H). After transient expression of *Cre* recombinase, the loxP-*Tfcp2l1-2A-Klf2-loxP* cassette was excised, as indicated by GFP expression ([Figure 2](#fig2){ref-type="fig"}I). In N2B27 only condition, GFP-positive cells differentiated ([Figure 2](#fig2){ref-type="fig"}J), indicating that the effect of *Klf2* and *Tfcp2l1* on ESC self-renewal is reversible. After excision of *Tfcp2l1-2A-Klf2* transgene, these ESCs could be induced to differentiate into GATA4-positive primitive endoderm cells, MYOSIN-positive mesoderm cells, and NESTIN-positive ectoderm cells in vitro and contributed to chimera formation after blastocyst injection ([Figures 2](#fig2){ref-type="fig"}K and 2L), suggesting that *Tfcp-Klf* mESCs remain pluripotent.

Downregulation of *Klf2* and *Tfcp2l1* Impairs ESC Self-Renewal {#sec2.3}
---------------------------------------------------------------

As shown above, forced expression of *Klf2* and *Tfcp2l1* is sufficient to maintain mESC self-renewal. Whether *Klf2* and *Tfcp2l1* are dispensable for mESC self-renewal in 2i condition, however, remains elusive. To address this question, we infected mESCs with lentiviruses encoding short-hairpin RNAs (shRNAs) specific to *Klf2* and *Tfcp2l1*. Stable knock down of these two genes was confirmed by qRT-PCR and western blot analyses ([Figures 3](#fig3){ref-type="fig"}A--3D). As expected, single knock down of either gene has no obvious effect on mESC self-renewal in 2i condition (data not shown). We then selected the shRNAs with the highest knockdown efficiency (*Klf2* shRNA \#2 and *Tfcp2l1* shRNA \#2) to simultaneously knock down both *Klf2* and *Tfcp2l1* in mESCs. Under 2i culture condition, *Klf2/Tfcp2l1* double knock down resulted in significant decrease of ESC colony forming efficiency, downregulation of pluripotency genes *Oct4*, *Nanog*, and *Rex1*, and upregulation of differentiation genes *Cdx2*, *T*, *Gata4*, *Foxa2*, and *Nestin* ([Figures 3](#fig3){ref-type="fig"}E--3H). These results suggest that *Klf2* and *Tfcp2l1* are necessary for mESC self-renewal mediated by 2i.

*Klf2* and *Tfcp2l1* Act Synergistically to Induce Naive Pluripotency {#sec2.4}
---------------------------------------------------------------------

The primed state mouse epiblast stem cells (EpiSCs) can be converted back to naive state ESCs by forced expression of reprogramming factors ([@bib3; @bib15]). To achieve such reprogramming, EpiSCs need to be cultured under 2i condition. Given that *Klf2* and *Tfcp2l1* can mimic the effect of 2i, we next examined whether forced expression of *Klf2* and *Tfcp2l1* is sufficient to both induce and maintain naive pluripotency. To this end, we first differentiated mESCs into EpiSCs as described previously ([@bib5]). The resulting EpiSCs stained negative for alkaline phosphatase (AP), expressed *Oct4* and *Fgf5*, a post-implantation epiblast-specific marker, and exhibited a significant downregulation of naive pluripotency markers *Rex1*, *Klf2*, and *Tfcp2l1* ([Figures 4](#fig4){ref-type="fig"}A and 4B), confirming their EpiSC identity. Next, we overexpressed *Klf2*, *Tfcp2l1*, or both in EpiSCs ([Figure 4](#fig4){ref-type="fig"}C). When cultured in serum/2i/LIF condition, EpiSCs overexpressing *Klf2* or *Tfcp2l1* gave rise to AP-positive ESC-like colonies within 8 days while EpiSCs transfected with empty PB vector died or differentiated within the same period of time ([Figure 4](#fig4){ref-type="fig"}D). As expected, EpiSCs overexpressing both *Klf2* and *Tfcp2l1* produced significantly more AP-positive colonies than those overexpressing *Klf2* or *Tfcp2l1* alone ([Figure 4](#fig4){ref-type="fig"}E). These EpiSC-converted ESC-like cells expressed high levels of naive pluripotency markers *Nanog* and *Rex1*, but low levels of primed state pluripotency maker *Fgf5* ([Figure 4](#fig4){ref-type="fig"}F), indicating the successful conversion from primed state back to naive state pluripotency.

Next, we tested whether *Klf2* and *Tfcp2l1* could induce naive state pluripotency in the absence of 2i. When cultured in serum/LIF condition, we observed that EpiSCs overexpressing both *Klf2* and *Tfcp2l1* could still be efficiently reprogrammed back to AP-positive ESC-like cells. In contrast, EpiSCs overexpressing *Klf2* or *Tfcp2l1* alone produced significantly less AP-positive colonies under the same condition ([Figures 4](#fig4){ref-type="fig"}G and 4H). The identity of the ESC-like cells converted from EpiSCs by overexpressing *Klf2* and *Tfcp2l1* in the absence of 2i was further confirmed by qRT-PCR ([Figure 4](#fig4){ref-type="fig"}I). Together, these results suggest that *Kfl2* and *Tfcp2l1* can act synergistically to reprogram EpiSCs to naive state ESCs in the absence of 2i.

Discussion {#sec3}
==========

In this study, we have shown that *Klf2* and *Tfcp2l1* are the two key downstream targets of Wnt/β-catenin responsible for mediating mESC self-renewal. Overexpression of *Klf2* and *Tfcp2l1* can recapitulate the self-renewal-promoting effect of 2i in mESCs, whereas downregulation of *Klf2* and *Tfcp2l1* impairs ESC self-renewal. *Klf2* and *Tfcp2l1* can also facilitate the reprogramming of EpiSCs back to the naive pluripotent state. Our study therefore establishes KLF2 and TFCP2L1 as two key mediators of mESC self-renewal promoted by 2i.

Inhibition of GSK3 has dual effects on mESCs: promoting self-renewal and inducing non-neural differentiation ([@bib18]). Previous reports have shown that CHIR exerts its function on promoting self-renewal through activation of canonical Wnt/β-catenin signaling pathway ([@bib6]). Upon Wnt ligand or CHIR treatment, β-catenin, the central effector of Wnt/β-catenin signaling pathway, induces the expression of several pluripotency genes, such as *Oct4*, *Sox2*, and *Nanog*, via suppression of TCF3 ([@bib6]). In recent reports, *Esrrb* has been shown as a Wnt/β-catenin target in 129-derived mESCs ([@bib6]). However, we did not observe such increase of *Esrrb* expression in our microarray data from C57BL/6-derived mESCs after CHIR treatment (GEO: [GSE50393](ncbi-geo:GSE50393){#intref0025}). Moreover, overexpression of *Esrrb* is not sufficient to support ESC self-renewal under serum-free condition (data not shown). On the contrary, *Klf2* and *Tfcp2l1*, two downstream targets of Wnt/β-catenin signaling pathway ([@bib6]), were upregulated upon CHIR treatment in our microarray data ([Figure 1](#fig1){ref-type="fig"}B) and play a pivotal role in mediating ESC self-renewal promoted by Wnt/β-catenin signaling ([Figures 2](#fig2){ref-type="fig"}D, 2E, and [3](#fig3){ref-type="fig"}C). Both KLF2 and TFCP2L1 can upregulate *Nanog* expression to promote ESC self-renewal ([@bib4; @bib15]) and *Esrrb* is a direct NANOG target gene that can substitute for NANOG function in mESCs ([@bib2]). Therefore, it would be of great interest in future studies to determine the connection between *Klf2/Tfcp2l1* and *Esrrb* in mediating ESC self-renewal.

Interestingly, KLF2 and TFCP2L1 are also involved in LIF/STAT3-mediated ESC self-renewal. KLF2, which is functionally redundant with KLF4, a known target of LIF/STAT3 signaling, can maintain mESCs in an undifferentiated state in the presence of serum ([@bib3]). TFCP2L1, a key target of LIF/STAT3 signaling pathway, can also largely substitute the effect of LIF on ESC self-renewal ([@bib7; @bib15]). Notably, both KLF2 and TFCP2L1 can partially replace the function of PD on promoting ESC self-renewal ([@bib15; @bib16]). However, when overexpressed alone, neither of them could maintain ESC self-renewal under serum-free condition in the absence of LIF and 2i ([Figure 2](#fig2){ref-type="fig"}D). It would be of great interest to explore how KLF2 and TFCP2L1 interact with each other in maintaining pluripotency.

Another important effect of KLF2 and TFCP2L1 we observed is to reprogram EpiSCs back to naive state ESCs ([Figures 4](#fig4){ref-type="fig"}D--4I). Both factors are highly expressed in mouse ESCs but barely detectable in EpiSCs ([@bib3; @bib15]). Previous studies have demonstrated that forced expression of each factor alone could reprogram EpiSCs back to ESCs when combined with 2i/LIF ([@bib3; @bib15]). In our study, we found that combined expression of *Klf2* and *Tfcp2l1* can convert EpiSCs back to ESCs in the absence of 2i ([Figures 4](#fig4){ref-type="fig"}G--4I), which is consistent with their function in mESC maintenance ([Figure 2](#fig2){ref-type="fig"}D). However, the underlying molecular mechanism of such a phenomenon needs to be further investigated. KLF2 and TFCP2L1 have been defined as two of the essential transcription factors for the induction of naive state pluripotency. Forced expression of *Klf2* in combination with another pluripotency factor *Nanog* is sufficient to induce naive state pluripotency in human ESCs, which share many defining features with mouse EpiSCs ([@bib12]). Additionally, depletion of *Tfcp2l1* in naive state human pluripotent stem cells collapses the naive pluripotent state ([@bib12]). *Tfcp2l1* is highly expressed in the inner cell mass of human blastocysts but significantly downregulated during derivation of human ESCs ([@bib10]), which suggests that TFCP2L1 might also play a role in establishing naive state pluripotency in human. Therefore, our study provides an expanded understanding of ESC self-renewal mechanism, a progress that might be critical in developing novel culture conditions for the derivation and maintenance of authentic ESCs from species other than rodents.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

mESCs were routinely cultured on 0.1% gelatin-coated dishes in DMEM medium (Invitrogen) supplemented with 10% FBS (HyClone), 1% MEM non-essential amino acids (Invitrogen), 2 mM GlutaMAX (Invitrogen), 0.1 mM β-mercaptoethanol (Invitrogen), and 100 U/ml LIF. For serum-free culture, mESCs were maintained in N2B27 medium ([@bib18]) supplemented with 3 μM CHIR and 1 μM PD (both synthesized in the Division of Signal Transduction Therapy, University of Dundee, UK).

Western Blot {#sec4.2}
------------

Cells were lysed in ice-cold RIPA cell buffer (TEKNOVA) supplemented with Protease Inhibitors Cocktail (Thermo Scientific). Total protein was separated on a 4%--20% PAGE gel (Bio-Rad). The primary antibodies used were TFCP2L1 (N-20, Santa Cruz, 1:200), KLF2 (09-820, Millipore, 1:2,000), FLAG (M2, Sigma, 1:2,000), and α-tubulin (32-2500, Invitrogen, 1:2,000).

EpiSC Derivation and Reprogramming {#sec4.3}
----------------------------------

For EpiSC derivation, 1 × 10^4^ 46C mESCs were plated into 0.1% gelatin-coated 35 mm dish and cultured in serum medium supplemented with Activin A (10 ng/ml, Peprotech), bFGF (10 ng/ml, Peprotech), and XAV939 (2 mM, Sigma). Cells were passaged every 3 days. For reprogramming, transfectants were seeded onto feeders-coated 6-well plates at a density of 1 × 10^5^ cells/well. After 24 hr, the medium was changed to DMEM/10% FBS medium supplemented with or without LIF/2i and replaced every other day. The number of AP-positive colonies was counted under microscope.

Blastocyst Injection {#sec4.4}
--------------------

Blastocysts were collected from E3.5 timed-pregnant C57BL/6 mice. mESCs (10--12) were injected into each blastocyst. mESC-injected blastocysts were transferred to E2.5 pseudo-pregnant CD1 mice. Animal experiments were performed according to the investigators' protocols approved by the USC Institutional Animal Care and Use Committee.

Statistical Analysis {#sec4.5}
--------------------

All data are reported as the mean ± SD. A Student's t test was used to determine the significance of differences in comparisons. Values of p \< 0.05 were considered as statistically significant.
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====================

D.Q. and S.Y. performed most of the experiments. B.R. and X.Z. carried out part of the experiments. Q.Z. and D.L. was involved in designing the experiments and analyzing the data. S.Y., D.Q., and Q.-L.Y. conceived and designed the study. D.Q., S.Y., X.Z., and Q.-L.Y. wrote the manuscript.

Accession Numbers {#app1}
=================

The accession number for the microarray dataset reported in this paper is Gene Expression Omnibus (GEO): [GSE50393](ncbi-geo:GSE50393){#intref0030}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures, Figure S1, and Tables S1 and S2Document S2. Article plus Supplemental Information

We thank Nancy Wu and Youzhen Yan for blastocyst injections. This work was supported by California Institute for Regenerative Medicine (CIRM) New Faculty Award II (RN2-00938), CIRM Scientific Excellence through Exploration and Development (SEED) (grant RS1-00327), Chen Yong Foundation of the Zhongmei Group, and in part by the Natural Science Foundation of China and Guangdong province (81370555, 81170452, S20120011190, and 2014B020228003), and Scientific Research Foundation of Anhui University (10117700027, 32030081, J10117700060, Y06050521, Y05201374, and Y06050519).

This is an open access article under the CC BY-NC-ND license (<http://creativecommons.org/licenses/by-nc-nd/4.0/>).

Supplemental Information includes Supplemental Experimental Procedures, one figure, and two tables and can be found with this article online at [http://dx.doi.org/10.1016/j.stemcr.2015.07.014](10.1016/j.stemcr.2015.07.014){#intref0035}.

![Genome-Scale Identification of Transcription Factors Involved in CHIR-Mediated ESC Self-Renewal\
(A) Flow chart illustrating the approach used to identify candidate genes regulated by CHIR and associated with mESC self-renewal (see also [Table S1](#mmc1){ref-type="supplementary-material"}).\
(B) Scatter plots of DNA microarray data showing *Asns*, *Zfhx2*, *Klf2*, *Tfcp2l1*, *Lefty2*, *Foxp1*, *Gadd45 g*, *Insm1*, and *Otx2* gene signal intensity from C57BL/6 mESCs cultured in serum/LIF/CHIR or serum/LIF for 24 hr.\
(C) qRT-PCR analysis of *Oct4*, *Klf2*, *Tfcp2l1*, and *Axin2* expression in C57BL/6 mESCs cultured in serum/LIF/CHIR or serum/LIF for 24 hr. Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus LIF.\
(D) Western blot analysis of 46C mESCs treated with LIF or LIF/CHIR for 24 hr.\
(E) AP staining of C57BL/6 mESCs transfected with *Klf2*, *Tfcp2l1*, and *Lefty2* and cultured in serum/LIF for two passages. Scale bar, 100 μm.](gr1){#fig1}

![Overexpression of *Klf2* and *Tfcp2l1* Can Replace 2i in Supporting mESC Self-Renewal in N2B27 Only Condition\
(A) Western blot analysis of 46C mESCs overexpressing the indicated transgenes.\
(B) AP staining of 46C mESCs overexpressing *Klf2*, *Tfcp2l1*, or both. ESCs were plated onto 6-well plates at a density of 2,000 cells/well and cultured in N2B27/PD condition for two passages. Top: representative images of AP staining in a 6-well plate. Bottom: representative images showing individual AP positive ESC colonies. Scale bar, 100 μm.\
(C) Immunofluorescence staining of PB-*Tfcp-Klf* mESCs cultured in N2B27/PD for five passages. Scale bar, 100 μm.\
(D) AP staining of colonies arisen from 46C mESC transfectants cultured in N2B27 only condition for two passages. Cells were plated at a density of 200 cells/well of a 6-well plate.\
(E and F) AP and immunofluorescence staining of PB-*Tfcp-Klf* mESCs cultured in N2B27 only condition for ten passages. NANOG immunostaining of 46C mESCs cultured in serum/LIF was used as a control (see also [Figure S1](#mmc1){ref-type="supplementary-material"}). Scale bar, 100 μm.\
(G) Diagram showing Cre excisable construct used for *Klf2* and *Tfcp2l1* overexpression.\
(H) AP staining of loxP-*Tfcp-Klf* mESCs cultured in N2B27 only condition for ten passages.\
(I) Phase contrast and GFP images of loxP-*Tfcp-Klf* mESCs after transfection with or without Cre expression plasmid. ESCs were cultured in serum/LIF condition. Scale bar, 100 μm.\
(J) AP staining of loxP-*Tfcp-Klf* mESCs (−*Cre*) and loxP-*Tfcp-Klf* mESCs in which the *Tfcp-Klf* transgene has been removed by Cre (+*Cre*). mESCs were cultured in N2B27 only condition for ten passages before AP staining.\
(K) Immunofluorescence staining of differentiated cells derived from loxP-*Tfcp-Klf* mESCs in which the *Tfcp-Klf* transgene has been removed by Cre. Scale bar, 100 μm.\
(L) Chimeric mouse embryos generated by injection of loxP-*Tfcp2l1*-*2A*-*Klf2*-loxP excised mESCs (GFP-positive) into C57BL/6 mouse blastocysts. Among 27 embryos analyzed between E11.5-E13.5, 13 contained GFP-positive cells.](gr2){#fig2}

![*Klf2* and *Tfcp2l1* Knock Down Impairs 2i-Mediated mESC Self-Renewal\
(A) qRT-PCR analysis of *Klf2* expression in *Klf2* shRNA knockdown 46C mESCs. Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus scramble shRNA.\
(B) Western blot analysis of KLF2 expression in *Klf2* shRNA knockdown 46C mESCs.\
(C) qRT-PCR analysis of *Tfcp2l1* expression in *Tfcp2l1* shRNA knockdown 46C mESCs. Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus scramble shRNA.\
(D) Western blot analysis of TFCP2L1 expression in *Tfcp2l1* shRNA knockdown 46C mESCs.\
(E and F) *Klf* sh\#2/*Tfcp2l1* sh\#2 double-knockdown 46C mESCs were cultured in N2B27/2i for 10 days. Representative images showing individual AP positive ESC colonies (E) and AP staining in a 6-well plate (F). Scale bar, 100 μm.\
(G) Quantification of AP-positive *Klf* sh\#2/*Tfcp2l1* sh\#2 mESC colonies as shown in (F). Data represent mean ± SD of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus scramble shRNA.\
(H) qRT-PCR analysis of gene expression in scramble shRNA and *Klf* sh\#2/*Tfcp2l1* sh\#2 knockdown mESCs cultured in N2B27/2i for two passages. Data represent mean ± SD of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus scramble shRNA.](gr3){#fig3}

![Forced Expression of *Klf2* and *Tfcp2l1* Facilitates Reprogramming of EpiSCs into Naive State ESCs\
(A) Phase contrast and AP staining images of EpiSCs converted from 46C mESCs after cultured in Activin A, bFGF, and XAV939 for ten passages (left). Right: 46C mESCs maintained in serum/LIF condition. Scale bar, 100 μm.\
(B) qRT-PCR analysis of gene expression in 46C mESCs and EpiSCs converted from 46C mESCs. Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus mESCs.\
(C) Western blot analysis of 46C EpiSCs transfected with the indicated transgenes.\
(D) Representative images showing AP staining of 46C EpiSCs transfected with the indicated transgenes and cultured in 2i/LIF for 15 days.\
(E) Quantification of AP-positive colonies in (D). Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus PB vector.\
(F) qRT-PCR analysis of gene expression in 46C EpiSCs and *Tfcp2l1/Klf2*-reprogrammed cells cultured in 2i/LIF. Data represent mean ± SD of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus *Tfcp2l1/Klf2*-reprogrammed cells.\
(G) Representative images showing AP staining of 46C EpiSCs 10 days after transfection with the indicated transgenes. Cells were cultured in LIF only condition. Scale bar, 100 μm.\
(H) Quantification of AP-positive colonies in (G). Data represent mean ± SD of three biological replicates. ^∗∗^p \< 0.01 versus PB vector.\
(I) qRT-PCR analysis of gene expression in 46C EpiSCs and *Tfcp2l1/Klf2*-reprogrammed cells cultured in LIF only condition. Data represent mean ± SD of three biological replicates. ^∗^p \< 0.05, ^∗∗^p \< 0.01 versus *Tfcp2l1/Klf2*-reprogrammed cells.](gr4){#fig4}
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